Intensive Chemotherapy
Showing 1 - 25 of >10,000
Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in
Not yet recruiting
- Acute Myeloid Leukemia
- (no location specified)
Sep 22, 2023
Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Neoplasm
- Magrolimab
- +2 more
- (no location specified)
Apr 24, 2023
Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)
Not yet recruiting
- Acute Myeloid Leukemia
- Venetoclax plus Azacitidine
- standard of care chemotherapy plus gemtuzumab ozogamicin
-
Essen, NRW, Germany
- +17 more
Jun 6, 2023
Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Venetoclax Oral Tablet
- +2 more
-
Bronx, New YorkMontefiore Einstein Cancer Center
Jul 14, 2022
Single-cell Dynamic Profiling in Newly Diagnosed Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- Biobanking blood and bone marrow specimens
- (no location specified)
Mar 21, 2022
Bacterial Prophylaxis and Validation of Sepsis Scores NEWS and
Recruiting
- Acute Myeloid Leukemia
-
Torino, ItalyAOU Città della Salute e della Scienza di Torino
Mar 25, 2022
Periodontitis and Blood Stream Infection in AML Patients
Terminated
- Acute Myeloid Leukemia
- Planned Chemotherapy
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 4, 2022
Acute Myeloid Leukemia Trial in Firenze (Venetoclax+Decitabine)
Recruiting
- Acute Myeloid Leukemia
-
Firenze, ItalyAz. Ospedaliero - Universitaria Careggi
Jan 3, 2022
Acute Myeloid Leukemia Trial in Marseille, Nice (Pharmacokinetic sampling, Vital status determination, Toxicity assessments)
Not yet recruiting
- Acute Myeloid Leukemia
- Pharmacokinetic sampling
- +3 more
-
Marseille, France
- +1 more
Sep 6, 2023
Disease State in Adult Acute Myeloid Leukemia Ineligible for
Recruiting
- Acute Myeloid Leukemia
-
Athens, Attiki, Greece
- +11 more
Jan 26, 2023
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (STAT
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- STAT Inhibitor OPB-111077
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Dec 20, 2022
Venetoclax Plasma Concentration and Remission in Acute Myeloid
Not yet recruiting
- Adult Acute Myeloid Leukemia
- Blood sampling for venetoclax drug dosage (venous puncture)
- (no location specified)
Sep 13, 2023
Hematologic Diseases, Chemo Effect Trial in France (MaaT033 capsule)
Completed
- Hematologic Diseases
- Chemotherapy Effect
- MaaT033 capsule
-
Angers, France
- +3 more
Apr 11, 2022
Disease State in Adult Acute Myeloid Leukemia Ineligible for
Recruiting
- Acute Myeloid Leukemia
-
Luzern 16, Luzern, Switzerland
- +9 more
May 2, 2022
Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- (no location specified)
Sep 18, 2023
AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)
Recruiting
- AML
- Acute Myeloid Leukemia
-
Charlottesville, VirginiaUniversity of Virginia
Jul 2, 2022
Hematological Malignancies Treated With Intensive Chemo Trial in Saint-Étienne (Tranexamic acid)
Recruiting
- Hematological Malignancies Treated With Intensive Chemotherapy
- Tranexamic acid
-
Saint-Étienne, FranceCHU de Saint-Etienne
Feb 7, 2022
Acute Monocytic Leukemia, Newly Diagnosed Trial in Suzhou (Chidamide, Azacitidine, Venetoclax)
Recruiting
- Acute Monocytic Leukemia
- Newly Diagnosed
- Chidamide
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
Oct 3, 2022
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Active, not recruiting
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +9 more
-
Sewell, New Jersey
- +4 more
Dec 13, 2022
Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
- Ivosidenib Oral Tablet
- Azacitidine
-
Vienna, Austria
- +3 more
Jun 8, 2023
CNS Cancer, CNS BRAIN Trial in Basking Ridge, Commack, New York (temozolomide followed by high dose busulfan and thiotepa)
Active, not recruiting
- CNS Cancer
- CNS BRAIN
- temozolomide followed by high dose busulfan and thiotepa
-
Basking Ridge, New Jersey
- +2 more
Oct 7, 2021
Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)
Not yet recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +5 more
-
Chicago, IllinoisNorthwestern University
Feb 16, 2023
Acute Myeloid Leukemia Patients Undergoing Intensive
Active, not recruiting
- Acute Myeloid Leukemia
- Sample Collection Blood
- Stool Sample
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
May 17, 2021
Acute Leukemia Trial in Denmark (Home-based chemo)
Completed
- Acute Leukemia
- Home-based chemotherapy
-
Aalborg, Denmark
- +5 more
May 22, 2021